DGX Valuation

Quest Diagnostics Inc

Add to Watchlist

Advanced Chart

163.850

-0.210(-0.130%)

Overview
Forecast
Valuation

DGX Relative Valuation

DGX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, DGX is overvalued; if below, it's undervalued.

Historical Valuation

Quest Diagnostics Inc (DGX) is now in the Fair zone, suggesting that its current forward PE ratio of 16.49 is considered Fairly compared with the five-year average of 14.56. The fair price of Quest Diagnostics Inc (DGX) is between 133.78 to 173.54 according to relative valuation methord.

Relative Value

Fair Zone

133.78-173.54

Current Price：162.92

Fair

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

2.62

P/B

Median3y

2.49

Median5y

2.56

5.13

FCF Yield

Median3y

6.72

Median5y

7.79

Competitors Valuation Multiple

The average P/S ratio for DGX's competitors is 1.18, providing a benchmark for relative valuation. Quest Diagnostics Inc Corp (DGX) exhibits a P/S ratio of 1.64, which is 39.53% above the industry average. Given its robust revenue growth of 14.55%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap

DGX.N

Quest Diagnostics Inc